MedTrace Logo

Genetic, Microbiological and Behavioral Factors in Obesity

NCT07650149 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-06-16

No results posted yet for this study

Summary

This study will assess the impact of genetic markers, microbiological (microbiome) and behavioral factors on tolerance, adherence and effectiveness of dual GLP1/GIP RA in the treatment of obesity.

200 consecutive patients who meet all inclusion and none of the exclusion criteria will be enrolled.

Conditions

  • Obesity & Overweight
  • Obesity
  • Genetics

Interventions

DIAGNOSTIC_TEST

genetic polymorphism

GLP1 RA and GIP R polymorphisms will be assesed from venous blood samples

DIAGNOSTIC_TEST

gut microbiome

stool samples and oral cavity swabs for gut microbiome will be collected to assess V3 and V4 of gene 16s rRNA

Sponsors & Collaborators

  • LUX MED Group

    collaborator OTHER

  • Jan Kochanowski University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-23
Primary Completion
2027-05-31
Completion
2028-05-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07650149 on ClinicalTrials.gov